PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 206 filers reported holding PDL BIOPHARMA INC in Q4 2015. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $144,000 | -33.3% | 40,800 | -4.9% | 0.00% | – |
| Q3 2015 | $216,000 | -21.7% | 42,900 | 0.0% | 0.00% | – |
| Q2 2015 | $276,000 | -26.2% | 42,900 | -19.3% | 0.00% | -100.0% |
| Q1 2015 | $374,000 | -25.1% | 53,139 | -18.0% | 0.00% | 0.0% |
| Q4 2014 | $499,000 | +20.8% | 64,820 | +17.0% | 0.00% | 0.0% |
| Q3 2014 | $413,000 | +8.1% | 55,392 | +40.2% | 0.00% | 0.0% |
| Q2 2014 | $382,000 | +16.5% | 39,500 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $328,000 | -1.5% | 39,500 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $333,000 | +5.7% | 39,500 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $315,000 | +1.6% | 39,500 | -1.7% | 0.00% | 0.0% |
| Q2 2013 | $310,000 | – | 40,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtus ETF Advisers LLC | 158,634 | $528,000 | 0.73% |
| TFS CAPITAL LLC | 795,409 | $2,649,000 | 0.38% |
| Dynamic Capital Management Ltd | 173,813 | $579,000 | 0.22% |
| Acrospire Investment Management LLC | 91,141 | $303,000 | 0.21% |
| GSA CAPITAL PARTNERS LLP | 905,024 | $3,014,000 | 0.19% |
| RBF Capital, LLC | 273,976 | $912,000 | 0.18% |
| Gotham Asset Management, LLC | 3,732,679 | $12,430,000 | 0.14% |
| Advisors Asset Management, Inc. | 2,362,054 | $7,866,000 | 0.13% |
| A.R.T. Advisors, LLC | 812,008 | $2,703,000 | 0.12% |
| Bayesian Capital Management, LP | 37,200 | $124,000 | 0.12% |